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Propionibacterium freudenreichii is a commercially relevant bacterium with probiotic
potential. This bacterium can exert protective effects particularly against colorectal
cancer (CRC), via the production of short chain fatty acids (SCFA), namely acetate and
propionate. In this work, we aimed to evaluate the performance and adaptation capacity
of P. freudenreichii to a simulated digestive stress using different culture media, namely
YEL, Basal medium, Mimicking the Content of the Human Colon medium (MCHC) and
DMEM. The effect of the fermented culture broth on CRC cells survival and of CRC cells
conditioned media on the bacteria performance was also evaluated. Basal medium was
found to be the best for P. freudenreichii to produce SCFA. MCHC medium, despite
being the medium in which lower amounts of acetate and propionate were produced,
showed higher acetate and propionate yields as compared to other media. We also
observed that the presence of lactate in CRC cells conditioned growth medium resulting
from cell metabolism, leads to an increased production of SCFA by the bacteria. The
bacterial fermented broth successfully inhibited CRC cells proliferation and increased
cell death. Our results showed for the first time that P. freudenreichii performance might
be stimulated by extracellular lactate produced by CRC metabolic switch also known
as “Warburg effect,” where cancer cells “ferment” glucose into lactate. Additionally,
our results suggest that P. freudenreichii could be potentially used as a probiotic in
CRC prevention at early stages of the carcinogenesis process and might help in CRC
therapeutic approaches.
Keywords: colorectal cancer, Propionibacterium freudenreichii, probiotic, short chain fatty acids, acetate,
propionate
INTRODUCTION
Colorectal cancer (CRC) constitutes a major concern in developed countries being associated to
lifestyle which is emerging as a critical element for its prevention (1). Evidences have shown that
low fat and high dietary fiber diet could be protective against CRC (2–4). The major impact of
diet habits on the prevalence of CRC has triggered the design of an optimal diet regimen and/or
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the development of food supplements specifically reducing the
risk of cancer (5–7). A growing interest on the use of probiotics
as cancer-preventing/treating agents has been registered (8, 9).
Propionibacteria is an important class of probiotics that is
well-known for its long history of consumption in Swiss type
cheeses (10). During the cheese making process, P. freudenreichii
resists the harsh physical and chemical stresses exhibiting a
high resistance to the digestive stresses which is essential for its
survival in the gut and also for exerting its beneficial effects (11,
12). P. freudenreichii health beneficial properties are a result of the
broad variety of its functional metabolites, including acetate and
propionate (10, 13–15). Short chain fatty acids (SCFA), namely
acetate, propionate and butyrate, are naturally present in the
human gut. SCFA are required to balance the redox equivalent
production in the anaerobic environment of the gut, as well as to
maintain the intestinal homeostasis (5, 16). Several studies have
showed a variety of biological effects of SCFA, and there is a
vast number of reports, some of them from our group, showing
new mechanisms underlying the effects of these molecules (17–
23). SCFA may have opposing effects either inducing/inhibiting
autophagy and hence inhibiting proliferation of cancer cells
or inducing apoptosis (24–26). In this sense, our group has
recently demonstrated that acetate induces lysosomal membrane
permeabilisation and the release of Cathepsin D (22). Moreover,
we showed that Cathepsin D protects the CRC cells from acetate-
induced apoptosis through autophagy-independent degradation
of damaged mitochondria (23). The anti-neoplastic effects of
P. freudenreichii have been evaluated by several research groups
(11, 12, 15, 17, 27, 28). Jan et al. (17) demonstrated that the
Propionibacterium strains induce cell death in human cancer
cell lines, such as HeLa, HT29 and Caco2 cells, apparently via
the SCFA produced. Lan et al. (28) demonstrated in an in vivo
study, that P. freudenreichii TL133, via its metabolites, facilitated
the elimination of damaged cells by apoptosis in the rat colon
after genotoxic insult and may play a protective role against
CRC. Maintaining SCFA in the gut, at levels that protect normal
colon mucosa cells and kill CRC cells is of utmost relevance for
the CRC prevention and/or therapy. Therefore, our aim was to
evaluate the SCFA production capacity of P. freudenreichii subsp.
freudenreichii, as well as to study the bacteria capacity to adapt
to the digestive stress. Additionally, we aimed to evaluate the
influence of the bacteria medium on CRC cells survival and on
the other hand the effect of CRC cells conditioned medium in
bacteria performance in order to better understand the crosstalk
between P. freudenreichii and CRC cells.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Propionibacterium freudenreichii subsp. freudenreichii DSM
20271 was purchased from DSMZ (German collection of
microorganisms and cell cultures). Freeze dried bacteria were
reactivated and routinely cultivated on yeast extract-lactate (YEL)
medium at 37◦C without agitation. A P. freudenreichii tolerant
to a simulated digestive stress (adapted bacteria) was also used.
P. freudenreichii adaptation was performed as described by Lan
et al. (12) with some modifications. Briefly, the digestive stress
adaptation was performed by exposing the bacteria to pH 5.0
(1 h), pH 2.0 (0.5 h) and finally to 0.1% (w/v) bile salts (2 h).
The experiment was performed at 37◦C without agitation and
under anaerobic conditions. The P. freudenreichii subjected to a
digestive stress challenge was further inoculated in liquid MCHC
in order to recover a robust adapted bacterial culture. After
growth (up to OD650nm of 0.8–1.0), the adapted bacterial culture
was transferred to fresh liquid MCHC media to reactivate its
metabolism and was characterized regarding growth and SCFAs
production in different media.
Cultures of normal and adapted P. freudenreichii were grown
under anaerobic conditions at 37◦C without agitation and
monitored at defined time points (0, 16, 24, 40, 48, 64, and
72 h) by measuring the absorbance of cell suspensions at 650 nm
in a spectrophotometer (Hach, Germany). The culture media
used to grow the bacteria were: YEL medium (tryptone, 10 g
L−1; sodium acetate, 8.4 g L−1; yeast extract, 5 g L−1; resazurine
0.5mg L−1; KH2PO4, 0.5 g L
−1; Na2HPO4.H2O, 0.5 g L
−1;
1mL L−1 of trace element H+ solution; 1mL L−1 of trace
element OH− solution; 50mL L−1 of salts and vitamins solution;
50mL L−1 of bicarbonate solution). Trace elements H+ solution
contains HCl (1.8 g L−1), H3BO3 (61.8mg L
−1), MnCl2 (61.3mg
L−1), FeCl2 (1.0 g L
−1), CoCl2 (64.5mg L
−1), NiCl2 (12.9mg
L−1), and ZnCl2 (67.7mg L
−1). Trace elements OH− solution
contains NaOH (0.4 g L−1), Na2SeO3 (17.3mg L
−1), Na2WO4
(29.4mg L−1), and Na2MoO4 (20.5mg L
−1). The salts and
vitamins solution contains NH4Cl (24 g L
−1), NaCl (24 g L−1),
MgCl2.6H2O (8 g L
−1), CaCl2.2H2O (8.8 g L
−1), biotin (20mg
L−1), nicotamid (0.2 g L−1), p-aminobenzoic acid (0.1 g L−1),
thiamin (0.2 g L−1), panthotenic acid (0.1 g L−1), pyridoxamine
(0.5 g L−1), cyanocobalamine (0.1 g L−1), riboflavin (0.1 g L−1),
folate (50mg L−1), and lipoate (50mg L−1). The bicarbonate
solution contains NaHCO3 (80 g L
−1), and Na2S.9H2O (5 g L
−1).
Basal medium (BM) is similar to YEL medium but without
tryptone and containing 1 g L−1 of yeast extract. The medium
“mimicking the content of the human colon” (MCHC) (29)
is composed by pectin (0.5 g L−1), xylan (0.5 g L−1), mucin
(0.5 g L−1), starch (0.5 g L−1), peptone (0.5 g L−1), tryptone
(2.5 g L−1), yeast extract (0.5 g L−1), bile salts (0.05 g L−1),
K2HPO4 (2.0 g L
−1), NaHCO3 (0.2 g L
−1), NaCl (4.5 g L−1),
MgSO4.7H2O (0.5 g L
−1), CaCl2.2H2O (0.45 g L
−1), MnCl2
(0.2 g L−1), haemin (50mg L−1), FeSO4.7H2O (5.0mg L
−1),
CoCl2.6H2O (50mg L
−1), tween 80 (2.0mL L−1), sodium lactate
(2.3 g L−1), thiamine HCl (4.0 µg L−1), calcium pantothenate
(10 µg L−1), nicorinic acid (5.0 µg L−1), p-aminobenzoic
acid (5.0 µg L−1), biotin (2.0 µg L−1), vitamin B12 (0.5 µg
L−1), and cysteine (0.8 g L−1). Dulbecco‘s Modified Eagle‘s
Medium (DMEM; Biowest, France) supplemented with 10%
(v/v) heat inactivated fetal bovine serum (FBS; Biowest, France)
was also used to grow bacteria cultures. Bacteria were also
cultured in CRC cells conditioned medium which consists in the
supernatants collected after CRC cells growth. CRC cells were
cultivated in 75 cm2 tissue culture flasks (TPP, German) at a
density of 20 × 104 cell mL−1, using DMEM medium without
antibiotic. The CRC conditioned medium was collected after
72 h of incubation and was then diluted (1:1) in fresh DMEM
medium.
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Analysis of Small Chain Fatty Acids,
Glucose, and Biomass
Lactate, acetate and propionate were analyzed by high-
performance liquid chromatography (HPLC) equipped with an
UV detector (Jasco, Spain) using a Metacarb 67H column
(Varian, USA) operated at 60◦C with 0.01N H2SO4 as the mobile
phase at an 0.6mL min−1 flow rate. Glucose concentration
was measured using the same HPLC system but equipped with
a Metacarb 87H column (Varian, USA) and a RI detector
(KNAUER, German) operated using the same conditions of
temperature and mobile phase and a flow rate of 0.7mL min−1.
Samples for further analysis were centrifuged at 10 000 g for 5min
(Eppendorf, Spain), filtered with 0.2µm filters (GE Healthcare
Life Science, Germany). Standard solutions of acetate, propionate
and glucose were used in a wide range of concentrations (0–10 g
L−1) was used to elaborate the calibration curves. An area of “x”
represents (0.0034x −0.0027; R2 = 0.9988), (0.0032x −0.0027;
R2= 0.9991) and (0.0026x+ 36.1222;R2= 0.9992) g L−1 (for x>
0) of acetate, propionate and glucose, respectively.
Biomass was determined from a standard curve of optical
density vs. dry weight. Dry weights for the standard curve were
obtained by filtering the culture through 0.2µm filters. After
filtration, the filters were dried and weighed. The standard curve
was plotted from the mean values of two determinations, and the
biomass was obtained from the least-squares regression line. All
fermentations were performed in triplicated, except the DMEM
fermentation which was performed in duplicated.
CRC Cells Culture Conditions
The human CRC derived cell line RKO (CRL-2577) was kindly
provided by IPATIMUP. Cells were grown as monolayers at 37◦C
in a humidified incubator with 5% CO2, in DMEM medium
supplemented with 10% (v/v) FBS and 1% (v/v) penicillin-
streptomycin (Invitrogen, Portugal). RKO cells were kept in
exponential growth phase and subcultured once or twice a week.
For the assays, subconfluent cells, in exponential growth phase,
were detached with trypsin/EDTA (Invitrogen, Portugal) and
ressuspended in fresh medium at the appropriate density.
CRC Cells Proliferation Assay
In all treatments performed in this work, cells in exponential
growth phase were cultured in 24-well plates at a cellular density
of 1 × 105 cell mL−1 in a final volume of 0.5ml per well,
excluding the cell cycle analysis in which cells were cultured in
6-well plates at a cellular density of 1.5 × 105 cell mL−1 in a
final volume of 1.5mL per well. Cells were incubated at 37◦C
in a 5% CO2 atmosphere during 24 h, to allow cell adhesion.
After adhesion, the culture medium was removed and replaced
by different treatment conditions.
To evaluate the effect of pure acetate (sodium acetate;
pH 7.1–7.4) and propionate (sodium propionate; pH 7.1–
7.4) on CRC cells proliferation, cells were treated with the
pure acids, acetate and propionate, at different concentrations
either alone or combined. The half maximal inhibitory
concentration (IC50) (6.6 g L
−1; 4.4 g L−1) and 30% maximal
inhibitory concentration (IC30) (4.4 g L
−1; 2.9 g L−1) of acetate
and propionate [concentrations previously determined in our
lab (22)], respectively, were used. Pure acids at the same
concentration of acetate (0.79 g L−1) and propionate (2.6 g L−1)
that were detected in the DMEM fermented broth were used to
treat CRC cells for 48 h. Hydrogen peroxide (1mM) was used
as a positive control, while fresh DMEM medium was used as
negative control. Both control media conditions have in their
composition 1% (v/v) penicillin-streptomycin. The absence of
Mycoplasm contamination was regularly evaluated in the cell
lines according to the laboratory regulation.
To evaluate the effect of the SCFA produced by adapted and
normal (non-adapted) P. freudenreichii on the CRC cells, cells
were treated with BM and DMEM fermented broths by adapted
and normal bacteria diluted (1:1) in fresh DMEM medium.
Fermented broths were collected after bacterial growth through
centrifugation at 10,000 g for 20min (HERAEUS, Germany) and
filtration using sterile filters of 0.2µm. The fermented broth pH
was adjusted to 7.10−7.40 and kept at −20◦C with parafilm. A
part of the fermented broth was sterilized (121◦C; 15min; 1 bar)
to obtain deproteinized fermented broth. Hydrogen peroxide
(1mM) was used as a positive control; DMEM medium diluted
(1:1) in sterile BM medium as negative control for the BM
fermented broth and DMEM medium diluted (1:1) in CRC
cells conditioned medium as a negative control for the DMEM
fermented broth. CRC cells conditioned medium used in this
context was a DMEM medium depleted of nutrients. Tissue
culture flask of 25 cm2 containing CRC cultures were maintained
for a week without replacing the culture media, assuring that all
the nutrients in the medium were consumed. After 1 week in
culture, the RKO conditioned medium was removed to a 15mL
falcon and the supernatant was collected through centrifugation
at 1,000 g for 10min. Controls containing the pure SCFA at the
same concentrations present in fermented broths were also used.
The sulforhodamine B (SRB) assay was used to access cell
proliferation. After treatments, cells were fixed in ice-cold
methanol containing 1% acetate, and incubated with SRB for
1.5 h at 37◦C. After washing with 1% acetate, the SRB was
solubilized (10mM Tris, pH 10) and absorbance was read at
540 nm in a microplate reader (Molecular Devices, USA). Results
were expressed relatively to the negative control, which was
considered as 100% of cell proliferation.
Cell Cycle Analysis
After 48 h of treatment, cells were harvested by scraping and
the medium was collected and centrifuged at 500 g for 3min.
The pellet was resuspended in 500 µL PBS 1x and incubated
on ice for 15min. After this period, 1.5ml of 96% (v/v) cold
ethanol (stored at −20◦C) was added to the pellet and was
incubated on ice during 15min, to allow cell fixation. Cells were
then washed with 4ml PBS 1x, centrifuged at 500 g for 3min at
4◦C and the pellet again washed with PBS 1x. The final pellet
was resuspended in 500 µL PBS 1x and was incubated with 50
µL of RNase A solution [200 µg mL−1 in sodium citrate 1%
(w/v)] at 37◦C for 15min. After incubation, 50 µL propidium
iodide (PI) staining solution [0.5mg mL−1 in sodium citrate
1% (w/v)] was added and the cells were mixed in a vortex and
were incubated at room temperature for 30min in the dark. Cells
with red fluorescence [FL-3 channel (488/620 nm)] were analyzed
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in Epics XL flow cytometer (Beckman Coulter, USA) with an
average of 20,000 counts per sample. Data were analyzed with the
Flowing software program (Perttu Terho, Finland) to generate
DNA content frequency histograms and quantify the amount of
cells in the individual cell-cycle, including sub-G1 population
assumed as death cells.
Statistical Analysis
Results correspond to the mean ± standard error of the mean
(SEM) of at least three independent experiments. The data
were analyzed using an analysis of variance (one-way ANOVA)
followed by Tukey’s Test to compare all the experiments or
Dunnett‘s test to assess the differences between control and
different conditions tested. The confidence interval used was
95% and p ≤ 0.05 were regarded as statistically significant. All
statistical tests were performed using the software Graphpad
Prism 5.
RESULTS
Production of Short Chain Fatty Acids by
P. freudenreichii
Propionibacterium freudenreichii was grown and characterized
regarding biomass and SCFA production in different culture
media. The results obtained are illustrated in Figure 1.
Biomass production reached ∼0.86 ± 0.02; 0.53 ± 0.01; 0.25
± 0.01, and 1.55 ± 0.01 g L−1 in YEL, BM, MCHC, and DMEM
media, respectively. The acetate production was found to be
around 1.65 ± 0.01; 1.81 ± 0.01; 0.58 ± 0.02, and 0.79 ±
0.02 g L−1 in YEL, BM, MCHC, and DMEM media, respectively;
while the propionate production was around 4.69± 0.01; 4.81±
0.02; 1.37 ± 0.03, and 2.60 ± 0.05 g L−1 in YEL, BM, MCHC,
and DMEM media, respectively. These results showed that
higher amounts of biomass production were not correlated with
higher amounts of SCFA production. For instance, in DMEM,
the bacteria exhibited higher amounts of biomass production;
however, lower amounts of SCFA were produced. In MCHC,
the bacteria displayed lower amounts of both biomass and SCFA
production. The higher production of SCFA was obtained using
BM, followed by the YEL medium.
Growth rates, yields and productivities were determined for
all culture media tested and are summarized in Table 1. Bacteria
grown in DMEM exhibited the highest biomass production
when compared to the other culture media evaluated, but
showed lower acetate and propionate productivities. Although
the lower amounts of acetate and propionate production by
P. freudenreichii were obtained in MCHC medium, the acetate
and propionate yields are high as compared to other media.
P. freudenreichii Adaptation to Simulated
Digestive Stress
The probiotic efficiency of P. freudenreichii depends on its
capacity to survive the digestive tract stresses and to remain
metabolically active in the gut. In order to obtain bacteria tolerant
to this type of stress, a digestive stress challenge was performed.
P. freudenreichii was exposed to acidic pH for 1.5 h and bile
salts concentrations for 2 h, mimicking the digestion process. The
performance of adapted P. freudenreichii was evaluated and the
results obtained are presented in Table 1.
Adapted P. freudenreichii displayed an increase in the
biomass concentration and growth rate, in DMEM and MCHC
media, when compared to the performance of the non-adapted
P. freudenreichii. However, the production of SCFA, particularly
propionate production, were negatively affected by the digestive
stress challenge. Significant statistical differences could be
observed between YEL and BM medium (p < 0.001) when
comparing the results obtained for the normal and adapted
bacteria (digestive stress challenged bacteria). This effect was
also observed for acetate production. Interestingly, the adapted
P. freudenreichii acetate yields in MCHC media were positively
affected by the digestive stress challenge showing a slight increase
(Table 1).
Effect of Colorectal Cancer Extracellular
Medium on Propionibacteria Performance
The effect of co-culture of CRC cells with probiotic bacteria in
the production of SCFA in normal and adapted P. freudenreichii
was studied through simulation using medium where CRC
cells were grown (conditioned medium). The diluted and non-
diluted conditioned medium containing 2.7 and 1 g L−1 of
glucose, respectively, were used to simulate the effect of CRC
cells in the growth of normal (non-adapted) P. freudenreichii
and on SCFAs production. Diluted and non-diluted conditioned
medium containing 3.2 and 1.8 g L−1 of glucose, respectively,
were used with the same purpose for the adapted bacteria. As
controls, fresh DMEM medium with the same concentrations
of glucose present in the conditioned medium were used. The
results presented in Figure 2 showed that bacteria growth was
negatively affected by CRC cells conditionedmedium (simulating
its indirect contact). A slow growth with a long stationary phase
was observed, although the final biomass concentration was
similar to the control. Adapted and non-adapted P. freudenreichii
growth in conditioned medium exhibited similar behaviors.
Growth and SCFA production parameters are summarized in
Table 2. We could observe statistically significant differences
for bacteria grown in conditioned medium comparing to the
controls. Yield and productivity parameters of acetate and
propionate show also statistically significant increase between
conditioned medium and the respective controls. Overall, the
conditioned medium led to a better bacteria performance
regarding the production of SCFA.
The increased SCFA production in conditioned medium
could be due to the presence of some metabolites produced by
CRC cells that are positively assimilated by bacteria. In order
to identify such compounds, present in conditioned medium
which could explain the improved SCFA production, CRC cells
conditioned medium diluted and non-diluted with fresh DMEM
medium were analyzed by HPLC.
The HPLC analyzed showed that lactate was detected in
the conditioned medium but not in the controls, what is
in accordance to the production of lactate by CRC cells
metabolism switch, also known as “warbourg effect” where cancer
cells “ferment” glucose into lactate. Non-diluted and diluted
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FIGURE 1 | Biomass, acetate and propionate production profiles by Propionibacterium freudenreichii in YEL, BM, MCHC, and DMEM media, at 37◦C. Each condition
was run in triplicate and the results correspond to the mean ± standard error of the mean.
conditionedmedium used to culture normal P. freudenreichiiwas
composed of 2.4 and 0.9 g L−1 of lactate, respectively, while 1.6
and 0.8 g L−1 of lactate was quantified in non-diluted and diluted
conditioned medium used to culture adapted P. freudenreichii.
The presence of lactate in CRC cells conditioned medium diluted
and non-diluted with fresh DMEM can explain the improvement
of the biotransformation performance by probiotic bacteria given
that lactate is the favorite carbon source for these bacteria.
Effect of Short Chain Fatty Acids Produced
by Propionibacteria on Colorectal Cancer
Cells Proliferation
In order to evaluate the effect of acetate and propionate produced
by bacteria on CRC cell proliferation by SRB assay, cells were
treated with concentrations similar to those obtained in the
bacteria medium. The IC50 and IC30 values of acetate (4.4;
6.6 g L−1) and propionate (2.9; 4.4 g L−1) alone were previously
determined in our laboratory (22). As a comparison, the cells
were incubated with acetate or/and propionate (between pH
7.1–7.4) at the IC50 and IC30 concentrations for 48 h (Figure 3).
The IC50 concentration of acetate and propionate reduced
cell proliferation by ∼53 and 46%, respectively. IC30 of acetate
and propionate led to a reduction in cell proliferation of 19
and 17%, respectively. An acetate concentration of 0.79 g l−1
led to a cell proliferation decrease of 7% with no statistical
differences when compared to the negative control. A propionate
concentration similar to that detected in DMEM fermented
broth by P. freudenreichii (2.6 g L−1) led to a decrease of 12%
in cell proliferation when compared with the negative control.
The combination of acetate and propionate exhibited a higher
effect in cell proliferation. The IC50 of acetate and propionate
together inhibited cell proliferation almost completely. The IC30
of acetate and propionate together reduced cell proliferation
by ∼80%, being higher than the effect of the IC30 of the
acids alone. Proliferation of CRC cells incubated with 0.79 g
L−1 of pure acetate and 2.6 g L−1 of pure propionate (i.e.
the SCFA concentrations present in DMEM fermented broth
by P. freudenreichii) was reduced by ∼21% being significantly
different from the negative control.
In order to evaluate the effect of the SCFA produced by
adapted and normal P. freudenreichii on the CRC cells, the
influence of the fermented broth was also analyzed. Among the
four fermented broths used, BM and DMEM were selected since
they showed no toxic effect to the CRC cells (data not shown).
BM diluted in fresh DMEM medium and CRC cells conditioned
medium diluted in fresh DMEMmedium were used as a negative
control of BM and DMEM fermented broths, respectively.
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TABLE 1 | Kinetics of the fermentations conducted with non-adapted and adapted (digestive stress challenged bacteria) Propionibacterium freudenreichii.
Non-adapted P. freudenreichii Adapted P. freudenreichii
YEL BM MCHC DMEM YEL BM MCHC DMEM
Biomass (g L−1) 0.86 ± 0.02 0.53 ± 0.01 0.25 ± 0.01 1.55 ± 0.01 0.80 ± 0.02 0.53 ± 0.03 0.39 ± 0.01*** 1.67 ± 0.01***





te Concentration (g L
−1) 1.65 ± 0.01 1.81 ± 0.01 0.58 ± 0.02 0.79 ± 0.02 1.53 ± 0.07 1.11 ± 0.03*** 0.61 ± 0.02 0.73 ± 0.01
Yield (g g−1) 0.18 ± 0.00 0.21 ± 0.01 0.22 ± 0.01 0.18 ± 0.00 0.18 ± 0.01 0.13 ± 0.00** 0.23 ± 0.01 0.18 ± 0.00







te Concentration (g L−1) 4.69 ± 0.01 4.81 ± 0.02 1.37 ± 0.03 2.60 ± 0.05 3.13 ± 0.10*** 2.91 ± 0.13*** 1.35 ± 0.05 2.72 ± 0.05
Yield (g g−1) 0.53 ± 0.00 0.55 ± 0.01 0.57 ± 0.01 0.57 ± 0.00 0.37 ± 0.01*** 0.35 ± 0.02*** 0.57 ± 0.02 0.66 ± 0.02
Productivity (g L−1 h−1) 0.09 ± 0.00 0.10 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.07 ± 0.00*** 0.06 ± 0.00*** 0.03 ± 0.00 0.04 ± 0.00
Different media were used to culture the adapted and non-adapted bacteria for 72 h at 37◦C without agitation. Na-Lactate was the carbon source in all media at an initial concentration
of 8.4 g L−1 (YEL and BM) and 2.3 g L−1 (MCHC), except for the DMEM medium in which glucose was used instead at an initial concentration of 4.1 g L−1 Each condition was run in
triplicate and the results correspond to the mean ± standard error of the mean. YEL, Yeast extract-lactate medium; BM, Basal medium; MCHC, Mimicking the Content of the Human
Colon medium; DMEM, Dulbecco‘s Modified Eagle‘s Medium; **p < 0.01; ***p< 0.001, values significantly different between the same medium.
Fermented broths were deproteinized (121◦C; 15min; 1 bar)
to eliminate any possible cytotoxic effect from contaminating
proteins. Diluted fermented broths contained 0.9 g L−1 of acetate
and 2.4 g L−1 of propionate for P. freudenreichii and fermented
broth of adapted P. freudenreichii, containing 0.6 g L−1 of
acetate and 1.5 g L−1 of propionate were used to treat colorectal
cancer cells. Cells were also treated with pure SCFA at the
concentrations previous described (SCFA control). Results of BM
andDMEM fermented broth by adapted and normal bacteria and
the respective controls are represented in Figure 4.
Inhibition of CRC cells proliferation was observed only with a
statistical significance (p < 0.01) in BM fermented broth from
normal P. freudenreichii. All conditions of DMEM fermented
broth (Figure 4B) showed an inhibition of cell proliferation
around 10–20%. No statistically significant differences were
found between BM fermented broth, BM fermented broth
deproteinized and the control with pure SCFA, indicating that
the effect of the fermented broths on CRC cells proliferation is
due to the bacterial SCFA cytotoxicity.
Cell cycle distribution of CRC treated with fermented broths
(BM and DMEM) and the respective controls was also studied
by flow cytometry measurement of the DNA content of cells
stained with PI (Figure 5). SCFA produced by normal and
adapted P. freudenreichii caused an accumulation of CRC cells
in the sub-G1 phase and a decrease in S and G2/M phases,
being significantly different compared to the negative control.
Moreover, higher accumulation of CRC cells in sub-G1 phase
(50–70%) was observed when cells were treated with BM
fermented broth than when cells were treated with DMEM
fermented broth (20–35%). Cells treated with DMEM fermented
broth also seem to be arrested in the G2/M phase of the cell-cycle
(10–30%).
DISCUSSION
Colorectal cancer is a leading cause of mortality in Europe (30),
and its occurrence is commonly attributed to the transformation
of normal colonic epithelium to adenomatous polyps and
ultimately invasive cancer (1). Environmental factors, namely
diet and lifestyle, have been reported in epidemiological studies
as responsible for the increase in CRC incidence (2–4, 6). SCFA,
particularly propionate and acetate, are known to have pro-
apoptotic effects (31, 32). These SCFA are the end product
of fermentation by physiological probiotic bacteria, such as
P. freudenreichii, which are present in several dairy products
frequently consumed (10, 33). A diet efficient in enhancing the
colonic content of SCFA may help to prevent or treat CRC,
as a preventive diet or as a complement to cancer therapy,
respectively.
In a previous report, our group have shown that acetate
per se inhibits proliferation and induces apoptosis, leading to
lysosomal membrane permeabilization with Cathepsin D release
from the lysosome in CRC cells (22). Likewise, we showed
that the CRC cells are protected by Cathepsin D from acetate-
induced apoptosis through autophagy-independent degradation
of damaged mitochondria (23). These observations suggest that
propionate and acetate, metabolites from propionibacteria could
make it a potential nutraceutical against CRC acting as a
probiotic, and pointing to a useful role of SCFA as powerful
agents for CRC prevention or therapy.
Although propionibacteria can be seen as a probiotic agent,
adaptation to the colonic lumen environment is critical to
confirm its potential. It is important that propionibacteria
survive and still produce the beneficial metabolites under
stress conditions such as host defense mechanisms including
pH variations, peristaltism, antimicrobial peptides, and bile
acids (34). The competition with resident microbiota for
nutrient acquisition and for growth niches needs also to
be taking in account (35). However, the influence of this
digestive stresses on the production of acetate and propionate
have never been investigated. In this work we aimed at
study the capacity of propionibacterium to adapt under the
digestive stress conditions and to evaluate its anti-cancer
capacity.
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FIGURE 2 | Biomass, acetate and propionate production profiles by non-adapted (A) and adapted (B) Propionibacterium freudenreichii at pH 7.0 and 37◦C in
non-diluted and diluted [with fresh DMEM (1:1)] colorectal cancer cells conditioned medium and the respective controls. Conditioned medium consists in the
supernatants collected after colorectal cancer cells growth in a DMEM medium without antibiotic for 72 h at 37◦C in a humidified incubator with 5% CO2. Each
condition was run in duplicate and the results are represented by the mean ± standard error of the mean.
Propionibacterium freudenreichii has a great potential
regarding the production of acetate and propionate as end-
products, although with different performances when grown
in different media. Results of SCFA production by normal
bacteria clearly showed that the BM medium provided the best
acetate and propionate productions, although it presented a yield
and productivity on propionate similar to the YEL medium.
Moreover, we have also observed that the MCHC medium
was not appropriate for bacteria growth being unfavorable to
produce SCFA. These conditions mimic the real scenario of
the gastrointestinal tract (GIT) and therefore indicate that the
digestive stress affects the probiotic capacity of propionibacteria,
although the production yield showed for acetate is high in
comparison to other media. Thus, further developments and
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TABLE 2 | Kinetics of the fermentations conducted with adapted and non-adapted Propionibacterium freudenreichii.
Non-adapted P. freudenreichii Adapted P. freudenreichii
CCM½ CM½ CCM CM CCM½ CM½ CCM CM
Biomass (g L−1) 1.34 ± 0.01 1.35 ± 0.04ns 0.66 ± 0.02 0.84 ± 0.03* 1.53 ± 0.00 1.65 ± 0.02ns 1.14 ± 0.05 1.20 ± 0.02ns





te Concentration (g L
−1) 0.66 ± 0.01 1.11 ± 0.06** 0.53 ± 0.02 1.32 ± 0.02*** 0.74 ± 0.00 1.07 ± 0.00*** 0.62 ± 0.00 1.19 ± 0.02***
Yield (g g−1) 0.24 ± 0.01 0.40 ± 0.02*** 0.56 ± 0.01 1.26 ± 0.01*** 0.23 ± 0.00 0.33 ± 0.00** 0.36 ± 0.02 0.66 ± 0.01***







te Concentration (g L−1) 2.21 ± 0.02 2.62 ± 0.06** 1.24 ± 0.05 2.48 ± 0.00*** 2.66 ± 0.02 2.92 ± 0.07ns 1.84 ± 0.05 2.53 ± 0.03**
Yield (g g−1) 0.78 ± 0.03 0.95 ± 0.02*** 1.3 ± 0.0 2.36 ± 0.06*** 0.82 ± 0.01 0.90 ± 0.02** 1.00 ± 0.01 1.40 ± 0.01***
Productivity (g L−1 h−1) 0.03 ± 0.00 0.04 ± 0.00** 0.020 ± 0.001 0.04 ± 0.00*** 0.04 ± 0.00 0.05 ± 0.00ns 0.03 ± 0.00 0.04 ± 0.00**
Colorectal cancer cells conditioned medium was used to culture the non-adapted and adapted bacteria. It consists of the supernatants collected after colorectal cancer cells growth in
a DMEM medium without antibiotic for 72 h at 37◦C in a humidified incubator with 5% CO2. Glucose was the carbon source present in this medium. Each condition was run in duplicate
and the results correspond to the mean ± standard error of the mean. *p < 0.05; **p < 0.01; ***p < 0.001, values significantly different between conditioned medium conditions and
respective controls; “ns” corresponds to non-significant differences. CM½, colorectal cancer cells conditioned medium diluted (1:1) in fresh DMEM; CCM½, control of diluted colorectal
cancer cells conditioned medium; CM, Colorectal cancer cells conditioned medium; CCM, control of colorectal cancer cells conditioned medium.
FIGURE 3 | Proliferation of colorectal cancer cells treated with pure acetate
and propionate either alone or combined. Cells were incubated for 48 h with
IC50, IC30 and the acetate and propionate concentrations similar to the ones
that were determined in the Propionibacterium freudenreichii fermented broth.
Fresh DMEM medium and hydrogen peroxide (1mM) were used as a negative
and positive control, respectively. Values represent the mean ± standard error
of the mean of at least three independent experiments.***p < 0.001,
compared with negative control cells. ##p < 0.01, ###p < 0.001,
comparing between condition.
optimizations of P. freudenreichii for the envisaged use must be
explored.
Lan et al. (12) cultured several strains of propionibacteria
in MCHC medium at 37◦C and evaluated the propionate
production. The authors found that a set of strains produced
propionate at concentrations around 1.32 g L−1, while other
strains produced lower amounts, thus suggesting that the
propionate production rate is strain-dependent. P. freudenreichii
subsp. freudenreichii, named TL3, produced 1.32 g L−1 of
propionate, which is similar to the propionate concentration
obtained in this study (1.4 g L−1). Jan et al. (17) using the
same conditions as the ones herein used in the fermentation of
DMEMmedium showed, with the strain ITG18 (P. freudenreichii
subsp. freudenreichii), that propionibacteria produced 2.7 g L−1
of propionate and 0.75 g L−1 of acetate. Therefore, the results
presented are in accordance with the literature.
In this work, we have successfully adapted P. freudenreichii
subsp. freudenreichii DSM 20271 to the digestive stress by
culturing cells in a simulated digestive stress media. Several
authors have performed digestive stress challenges to test the
adaptation and tolerance of propionibacteria (11, 12, 17, 33).
Being probiotics, these bacteria must be able to survive the
acid stress imposed within the stomach in order to reach
the intestine where they exert their beneficial role. In all the
studies reported, the authors could obtain a propionibacteria
adapted to the digestive stress, which was able to survive the
challenge similarly to our findings. Moreover, these studies
showed that the digestive stress tolerance is highly variable,
depending on the strain. The strain used in this work is described
as the one that presents the best survival rate during digestive
stress challenges (12). The adaptation of the P. freudenreichii
induced a negative impact on the production of propionate
in YEL and BM media. However, the performance of adapted
P. freudenreichii was not affected in the MCHC and DMEM
media for which a small increase of biomass production was
observed when compared with the results obtained for normal
P. freudenreichii.
Short chain fatty acids have been widely described in the
literature for its variety of biological effects and several reports
demonstrate the mechanisms of action of these molecules (19,
21, 22). Both SCFA and propionibacteria culture supernatants
from the dairy species P. freudenreichii and P. acidipropionici
induced apoptosis in CRC cells in vitro (17, 27, 28, 36). For
instance, Lan et al. (27) showed that 0.9 g L−1 of acetate and
2.2 g L−1 of propionate induced HT 29 colon cancer cells
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FIGURE 4 | Proliferation of colorectal cancer cells treated with BM (A) and DMEM (B) fermented broth by adapted and normal Propionibacterium freudenreichii.
Fermented broths were deproteinized to eliminate any possible cytotoxic effect from contaminating proteins. Pure SCFA at concentrations present on the fermented
broth of non-adapted bacteria (0.9 g L−1 acetate; 2.4 g L−1 propionate) or adapted bacteria (0.6 g L−1 acetate; 1.5 g L−1 propionate) were used as a SCFA control.
Cells were incubated for 48 h with BM and DMEM fermented broths and its respective controls. BM diluted in fresh DMEM medium and CRC cells conditioned
medium diluted in fresh DMEM medium were used as a negative control of BM and DMEM fermented broths, respectively, and Hydrogen peroxide (1mM) as a
positive control. Values represent the mean ± standard error of the mean of at least three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 compared
with negative control cells.
death by 50% at 48 h after incubation. Jan et al. (17) reported
that the DMEM fermented medium by P. freudenreichii subsp.
freudenreichii strain ITG18, containing 0.75 g L−1 of acetate
and 2.7 g L−1 of propionate at pH 5.6, was able to induce
cell death in HT29 colon cancer cells, and proved that the
cytotoxicity was due to the SCFA concentration present in
the supernatant. Our results using 0.79 g L−1 of acetate and
2.6 g L−1 of propionate showed a decrease of cell proliferation
by ∼21% in RKO cells and an induction of cell-cycle arrest
in the G2/M phase, not inducing a significant effect on cell
death. This might reflect the different sensitivity to SCFA of
the cell lines used, given that these cells have different genetic
backgrounds.
To study the potential antineoplastic effect of propionibacteria
fermented culture media on CRC cells, cells were treated with
DMEM and BM fermented broth by adapted and normal
P. freudenreichii for 48 h, as described previously. Regarding the
cell cycle distribution assessed in the treatments with SCFA and
SCFA produced by P. freudenreichii, our results showed a cell
cycle arrest and proliferation inhibition for all the conditions
evaluated (BM and DMEM fermented broth and the respective
controls) similarly to what was reported in our own, as well as
in others studies (22, 27). However, it is important to highlight
that we herein report for the first time the cytotoxic effect of the
fermented broth of a propionibacteria medium (BM) on CRC
cells.
Cancer cells are known for its biological capabilities acquired
during the multistep development of human tumors that
makes them act differently from normal cells (37). One of
these features is the ability to circumvent the immune system
taking advantage of the interaction with stromal cells (37).
Also, development of colorectal cancer is related to alterations
in the population of the gut microbiota [reviewed in (38)].
Therefore, we evaluated the effect of conditioned medium
by CRC cells on the propionibacteria performance, adapted,
and non-adapted to digestive stress. The results indicated
that propionibacteria grown in conditioned medium provide
higher SCFA production when compared with the respective
control, being this improvement more pronounced in the acetate
production. P. freudenreichii may be able to grow in co-culture
with CRC cell lines since a slower growth with an increased SCFA
production was observed. Moreover, our results demonstrated
that this biotransformation performance induced cell death
of CRC.
The improvement of SCFAs production in conditioned
medium may be due to the metabolites excreted by RKO cell
lines, namely lactate. Lactate is an ideal carbon source for
P. freudenrechii fermentation, leading to high propionate and
acetate yields (39). P. freudenrechii has a complex metabolism
that involves several metabolic pathways. Lactate consumption
yields pyruvate which can be reduced to produce propionate via
the transcarboxylase cycles, or oxidized to yield acetate and CO2
(40).
CRC is known to rely on glycolysis for energy production
and this activity leads to the production of important amounts
of lactate, which are exported into the extracellular milieu,
thus contributing to the acidic microenvironment (41, 42).
This phenomenon, known as “aerobic glycolysis” or “Warburg
effect” (43) and it leads to an accumulation of lactate (44). The
increased lactate production by CRC cells (42) may result, as
we observed in this work, in the increased production of SCFA
by Propionibacterium. Our results suggest that P. freudenreichii
promotes a cytotoxic effect on CRC cells, via their metabolites,
and that the CRC cells increases the acetate and propionate
production by P. freudenreichii, which in turn will lead to an
increased cytotoxic effect on the CRC cells.
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FIGURE 5 | Effect of the BM (A) and DMEM (B) fermented broth on cell cycle distribution. Analysis of the cell-cycle phase’s distribution: G0/G1; S; G2/M and
SUB-G1 in CRC cells treated with fermented broth from adapted and non-adapted P. freudenreichii and the respective controls. Fermented broths were deproteinized
to eliminate any possible cytotoxic effect from contaminating proteins. BM diluted in fresh DMEM medium and CRC cells conditioned medium diluted in fresh DMEM
medium were used as a negative control of BM and DMEM fermented broths, respectively. Hydrogen peroxide (1mM) was used as a positive control. Pure SCFA at
concentrations present on the fermented broth of non-adapted bacteria (0.9 g L−1 acetate; 2.4 g L−1 propionate) or adapted bacteria (0.6 g L−1 acetate; 1.5 g L−1
propionate) were used as a SCFA control. Values represent the mean ± standard error of the mean of at least three independent experiments. *p < 0.05; **p < 0.01;
***p < 0.001, comparing with negative control.
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CONCLUSIONS
Propionibacterium freudenreichii was able to produce high
amounts of acetate and propionate in BM and YEL media.
Adaptation of P. freudenreichii to digestive stress was successfully
obtained and its behavior was similar to the normal bacteria.
Interestingly, we observed a great improvement in the bacteria
performance using the MCHC and DMEM media which are
similar to the real scenario of the GIT. The effect of CRC cells
conditioned medium rich in lactate on the bacterial performance
showed that bacteria were able to grow remaining metabolically
active and produced more SCFA in the presence of lactate.
Furthermore, the exposure of CRC cells to SCFA produced by
Propionibacteria inhibited their proliferation and induced cell
cycle arrest. Our results suggest the use of P. freudenreichii as
a probiotic in the prevention and/or as therapeutic adjuvant
in CRC.
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